Enhancement of radiation damage in cellular dna following unifilar substitution with iododeoxyuridine

This publication has 17 references indexed in Scilit:

• Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme.
  Journal of Clinical Oncology, 1988
• Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Clinical experience with intravenous radiosensitizers in unresectable sarcomas
  Cancer, 1987
• Interaction of iododeoxyuridine and its primary metabolite, iodouracil on radiation response
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Analysis of the effect of DNA alkylation on alkaline elution
  Carcinogenesis: Integrative Cancer Research, 1986
• A phase i study of intravenous iododeoxyuridine as a clinical radiosensitizer
  International Journal of Radiation Oncology*Biology*Physics, 1985
• The use of halogenated thymidine analogs as clinical radiosensitizers: Rationale, current status, and future prospects: Non-hypoxic cell sensitizers
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.
  Journal of Clinical Investigation, 1983
• X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elution
  Nucleic Acids Research, 1979
• Development of a clonogenic cell assay for human brain tumors
  Cancer, 1978